Leucine Rich Bio launches enhanced BugSpeaks Skin Microbiome Test 2026 Edition: Our Bureau, Bengaluru Wednesday, September 9, 2026, 10:00 Hrs [IST] Leucine Rich Bio, South Asia’ ...

Novartis phase III HARBOR study of delpacibart etedesiran to treat myotonic dystrophy type 1 fails to meet primary endpoint: Basel Wednesday, September 9, 2026, 09:00 Hrs [IST] No ...

Indian pharmaceutical market clocked 10.7% growth in August driven by price realization & Mounjaro surge: Peethaambaran Kunnathoor, Chennai Wednesday, September 9, 2026, 08:00 Hrs ...

Expert asks NPPA to fix ceiling price for two early-stage breast cancer drugs abemaciclib and ribociclib: Our Bureau, New Delhi Wednesday, September 9, 2026, 08:00 Hrs [IST] The C ...

Fire safety must be embedded in healthcare design, not treated as an afterthought: Experts at FSIE 2026: Shardul Nautiyal, Mumbai Wednesday, September 9, 2026, 08:00 Hrs [IST] Fir ...

The Department-related Parliamentary Standing Committee on Health and Family Welfare has recommended to the ministry of health to mandate systematic pharmacoeconomic studies for all widely prescribed ...

India’s speciality pharma push to depend on scientific innovation and effective manufacturing processes: Nandita Vijayasimha, Bengaluru Wednesday, September 9, 2026, 08:00 Hrs [ ...

Obviously, it is a well thought out initiative as drug resistance cannot not be solved by guidelines alone. It can be solved at the patient's bedside, one clinical decision at a time. Those decisions ...

Alkem Laboratories Ltd. announced the launch of Renocia Exo, a next-generation hair regeneration therapy developed to support the health and vitality of the hair follicle through a comprehensive ...

US FDA approves Abbott’s TactiFlex Duo Ablation Catheter to treat people with abnormal heart rhythms: Abbott Park, Illinois Wednesday, September 9, 2026, 14:00 Hrs [IST] Abbott, ...

India’s clinical excellence and 60–80% lower healthcare costs offer huge potential to serve the world: Piyush Goyal: Our Bureau, Mumbai Wednesday, September 9, 2026, 13:50 Hrs ...

The Central Drugs Standard Control Organisation (CDSCO) is moving towards a smarter, risk-based regulatory approach that reduces and prioritises intervention, simplifies processes and applies greater ...